Loading
Latest filing published 17 Jul 2026 for 伟思医疗, €27k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 高飞 in 伟思医疗. Between 2 February 2023 and 17 July 2026, the trades on record add up to 5 filings.
Both buying and selling appear: 3 purchases worth €50k, against 2 sales worth €69k. Netting one side against the other leaves €19k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and 1 sale.
In size, the median ticket on the buying side is €14k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 17 July 2026, reports an open-market purchase of €27k in 伟思医疗. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations